ABCELY
About ABCELY
The startup develops immunotherapy technologies that utilize active therapeutic molecules to target mucosal cancers. By identifying and demonstrating the efficacy of biologically derived compounds, the company enhances treatment options for healthcare professionals, improving patient outcomes in oncology.
What does ABCELY do?
The startup develops immunotherapy technologies that utilize active therapeutic molecules to target mucosal cancers. By identifying and demonstrating the efficacy of biologically derived compounds, the company enhances treatment options for healthcare professionals, improving patient outcomes in oncology.
Where is ABCELY located?
ABCELY is based in Nantes, France.
When was ABCELY founded?
ABCELY was founded in 2022.
How much funding has ABCELY raised?
ABCELY has raised 2580000.
Who founded ABCELY?
ABCELY was founded by Olivier Favre-Bulle.
- Olivier Favre-Bulle - Founder/CEO
- Location
- Nantes, France
- Founded
- 2022
- Funding
- 2580000
- Employees
- 4 employees
- Major Investors
- GO CAPITAL